HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Teresa Caballero Selected Research

icatibant

12/2021Hereditary angioedema due to C1 inhibitor deficiency: real-world experience from the Icatibant Outcome Survey in Spain.
1/2021Continued icatibant use across recurrent attacks in adolescents with hereditary angioedema.
1/2019Pediatricians diagnosed few patients with childhood-presented hereditary angioedema: Icatibant Outcome Survey findings.
1/2019Elderly versus younger patients with hereditary angioedema type I/II: patient characteristics and safety analysis from the Icatibant Outcome Survey.
1/2018Improvement in diagnostic delays over time in patients with hereditary angioedema: findings from the Icatibant Outcome Survey.
1/2018Effectiveness of icatibant for treatment of hereditary angioedema attacks is not affected by body weight: findings from the Icatibant Outcome Survey, a cohort observational study.
11/2017Treatment Effect and Safety of Icatibant in Pediatric Patients with Hereditary Angioedema.
1/2017Breakthrough attacks in patients with hereditary angioedema receiving long-term prophylaxis are responsive to icatibant: findings from the Icatibant Outcome Survey.
6/2016The Icatibant Outcome Survey: treatment of laryngeal angioedema attacks.
9/2015Analysis of characteristics associated with reinjection of icatibant: Results from the icatibant outcome survey.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Teresa Caballero Research Topics

Disease

26Hereditary Angioedemas
03/2022 - 02/2006
9Angioedema
07/2021 - 06/2002
4Hypersensitivity (Allergy)
01/2016 - 08/2002
3Anaphylaxis (Anaphylactic Shock)
12/2014 - 02/2006
1Acquired Partial Lipodystrophy
06/2021
1Asthma (Bronchial Asthma)
01/2021
1Chronic Urticaria
01/2021
1Chronic Disease (Chronic Diseases)
01/2021
1Hereditary Angioedema Types I and II
01/2019
1Body Weight (Weight, Body)
01/2018
1Overweight
01/2018
1Peanut Hypersensitivity (Peanut Allergy)
08/2015
1Inborn Genetic Diseases (Disease, Hereditary)
01/2013
1Breast Neoplasms (Breast Cancer)
02/2012
1Insect Bites and Stings (Insect Bite)
06/2010
1Cutaneous Mastocytosis
06/2010
1Mast Cell Activation Disorders (Mast-Cell Disease)
06/2010
1Systemic Mastocytosis
06/2010
1Edema (Dropsy)
06/2009
1Occupational Asthma
05/2009
1Eosinophilic Esophagitis
09/2008
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
06/2002
1Rare Diseases (Rare Disease)
06/2002
1Acquired angioedema
06/2002

Drug/Important Bio-Agent (IBA)

12icatibantIBA
12/2021 - 01/2013
4AllergensIBA
01/2016 - 06/2010
3Complement C1 Inhibitor Protein (C1 Esterase Inhibitor)IBA
08/2021 - 01/2013
2Bradykinin B2 ReceptorIBA
12/2021 - 09/2015
2Complement System Proteins (Complement)IBA
06/2021 - 01/2016
2Gonadal Steroid Hormones (Sex Hormones)IBA
01/2021 - 11/2008
2Immunoglobulin E (IgE)IBA
08/2015 - 08/2002
2AndrogensIBA
02/2012 - 06/2009
1Complement Factor D (Factor D)IBA
06/2021
1Estrogens (Estrogen)FDA Link
01/2020
1Factor XII (Hageman Factor)IBA
01/2020
1BradykininIBA
01/2018
1Proteins (Proteins, Gene)FDA Link
01/2016
1Pepsin A (Pepsin)IBA
01/2016
1hypoxanthine arabinoside (ara-H)IBA
08/2015
1conglutininIBA
08/2015
1lipid transfer protein (glycolipid transfer protein)IBA
08/2015
1AlbuminsIBA
08/2015
1HemocyaninsIBA
12/2014
1Estrogen Receptor Modulators (Antiestrogen)IBA
02/2012
1Androgen Receptors (Androgen Receptor)IBA
06/2010
1Biological ProductsIBA
06/2010
1Tryptases (Tryptase)IBA
06/2010
1Growth Factor ReceptorsIBA
06/2010
1CyanoacrylatesIBA
05/2009
1Chemokine CCL26IBA
09/2008
1SteroidsIBA
09/2008
1Interleukin-5 (Interleukin 5)IBA
09/2008
1Chemokine CCL11IBA
09/2008
1Kallikreins (Kallikrein)IBA
02/2006
1AntibodiesIBA
02/2006
1ecallantideFDA Link
02/2006
1AutoantibodiesIBA
06/2002

Therapy/Procedure

10Therapeutics
03/2022 - 01/2008
2Self Administration (Administration, Self)
10/2018 - 02/2013